RECK regulated endoplasmic reticulum stress response and enhanced cisplatin-induced cell death in neuroblastoma cells

Surgery (United States)

Volumn 154, Issue 5, 2013, Pages 968-979

  Chen, Yun ^a,b   Tsai, Ya Hui ^a,b   Tseng, Sheng Hong ^c  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b YUAN ZE UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 4; CASPASE 7; CCAAT ENHANCER BINDING PROTEIN; CISPLATIN; GELATINASE A; GELATINASE B; GLUCOSE REGULATED PROTEIN 78; INITIATION FACTOR 2ALPHA; PROTEIN BAX; REVERSION INDUCING CYSTEINE RICH PROTEIN WITH KAZAL MOTIF; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; HEAT SHOCK PROTEIN; MOLECULAR CHAPERONE GRP78; RECK PROTEIN, HUMAN;

ARTICLE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; DNA TRANSFECTION; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IMMUNOPRECIPITATION; LIQUID CHROMATOGRAPHY; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; TANDEM MASS SPECTROMETRY; TUMOR GROWTH; VECTOR CONTROL; WESTERN BLOTTING; CELL SURVIVAL; DRUG EFFECTS; METABOLISM; NEUROBLASTOMA; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; UPREGULATION;

ANTINEOPLASTIC AGENTS; CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; CISPLATIN; ENDOPLASMIC RETICULUM STRESS; GPI-LINKED PROTEINS; HEAT-SHOCK PROTEINS; HUMANS; NEUROBLASTOMA; UP-REGULATION;

EID: 84886100910     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2013.05.026     Document Type: Article

References (34)

1. J.C. Clark, D.M. Thomas, P.F. Choong, and C.R. Dass RECK: a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer Cancer Metastasis Rev 26 2007 675 683
2. N. Meng, Y. Li, H. Zhang, and X.F. Sun RECK, a novel matrix metalloproteinase regulator Histol Histopathol 23 2008 1003 1010
3. M. Noda, and C. Takahashi Recklessness as a hallmark of aggressive cancer Cancer Sci 98 2007 1659 1665
4. S. Nagini RECKing MMP: relevance of reversion-inducing cysteine-rich protein with Kazal motifs as a prognostic marker and therapeutic target for cancer (a review) Anticancer Agents Med Chem 12 2012 718 725
5. Y. Chen, and S.H. Tseng The potential of RECK inducers as antitumor agents for glioma Anticancer Res 32 2012 2991 2998
6. Y. Chen, Y.H. Tsai, and S.H. Tseng Valproic acid affected the survival and invasiveness of human glioma cells through diverse mechanisms J Neurooncol 109 2012 23 33
7. D. Noujaim, C.M. van Golen, K.L. van Golen, A. Grauman, and E.L. Feldman N-Myc and Bcl-2 coexpression induces MMP-2 secretion and activation in human neuroblastoma cells Oncogene 21 2002 4549 4557
8. Q. Dong, D. Yu, C.M. Yang, B. Jiang, and H. Zhang Expression of the reversion-inducing cysteine-rich protein with Kazal motifs and matrix metalloproteinase-14 in neuroblastoma and the role in tumor metastasis J Exp Pathol 91 2010 368 373
9. M. Ni, Y. Zhang, and A.S. Lee Beyond the endoplasmic reticulum: atypical GRP78 in cell viability, signaling and therapeutic targeting Biochem J 434 2011 181 188
10. J. Li, and A.S. Lee Stress induction of GRP78/BiP and its role in cancer Curr Mol Med 6 2006 45 54
11. A.S. Lee The glucose-regulated proteins: stress induction and clinical applications Trends Biochem Sci 26 2001 504 510
12. Q.J. Quinones, G.G. de Ridder, and S.V. Pizzo GRP78: a chaperone with diverse roles beyond the endoplasmic reticulum Histol Histopathol 23 2008 1409 1416
13. A.S. Lee GRP78 induction in cancer: therapeutic and prognostic implications Cancer Res 67 2007 3496 3499
14. L.H. Zhang, and X. Zhang Roles of GRP78 in physiology and cancer J Cell Biochem 110 2010 1299 1305
15. D. Dong, L. Dubeau, J. Bading, K. Nguyen, M. Luna, and H. Yu Spontaneous and controllable activation of suicide gene expression driven by the stress-inducible grp78 promoter resulting in eradication of sizable human tumors Hum Gene Ther 15 2004 553 561
16. D. Dong, B. Ko, P. Baumeister, S. Swenson, F. Costa, and F. Markland Vascular targeting and antiangiogenesis agents induce drug resistance effector GRP78 within the tumor microenvironment Cancer Res 65 2005 5785 5791
17. C.C. Jiang, Z.G. Mao, K.A. Avery-Kiejda, M. Wade, P. Hersey, and X.D. Zhang Glucose-regulated protein 78 antagonizes cisplatin and adriamycin in human melanoma cells Carcinogenesis 30 2009 197 204
18. Y. Lin, Z. Wang, L. Liu, and L. Chen Akt is the downstream target of GRP78 in mediating cisplatin resistance in ER stress-tolerant human lung cancer cells Lung Cancer 71 2011 291 297
19. Y. Ma, and L.M. Hendershot The role of unfolded protein response in tumor development: friend or foe? Nat Rev Cancer 4 2004 966 977
20. A.C. Ranganathan, L. Zhang, A.P. Adam, and J.A. Aguirre-Ghiso Functional coupling of p38-induced upregulation of BiP and activation of RNA-dependent protein kinase-like endoplasmic reticulum kinase to drug resistance of dormant carcinoma cells Cancer Res 66 2006 1702 1711
21. L. Zhang, S. Wang, Wangtao, Y. Wang, J. Wang, and L. Jiang Upregulation of GRP78 and GRP94 and its function in chemotherapy resistance to VP-16 in human lung cancer cell line SK-MES-1 Cancer Invest 27 2009 453 458
22. G.M. Brodeur Neuroblastoma: biological insights into a clinical enigma Nat Rev Cancer 3 2003 203 216
23. J.R. Park, A. Eggert, and H. Caron Neuroblastoma: biology, prognosis, and treatment Pediatr Clin North Am 55 2008 97 120
24. A.D. Pearson, C.R. Pinkerton, I.J. Lewis, J. Imeson, C. Ellershaw, and D. Machin High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomized trial Lancet Oncol 9 2008 247 256
25. D. Dong, C. Stapleton, B. Luo, S. Xiong, W. Ye, and Y. Zhang A critical role for GRP78/BiP in the tumor microenvironment for neovascularization during tumor growth and metastasis Cancer Res 71 2011 2848 2857
26. K.H. Huang, K.L. Kuo, S.C. Chen, T.I. Weng, Y.T. Chuang, and Y.C. Tsai Down-regulation of glucose-regulated protein (GRP) 78 potentiates cytotoxic effect of celecoxib in human urothelial carcinoma cells PLoS One 7 2012 e33615
27. A. Mozos, G. Roue, A. Lopez-Guillermo, P. Jares, E. Campo, and D. Colomer The expression of the endoplasmic reticulum stress sensor BiP/GRP78 predicts response to chemotherapy and determines the efficacy of proteasome inhibitors in diffuse large B-cell lymphoma Am J Pathol 179 2011 2601 2610
28. O. Makarova, E. Kamberov, and B. Margolis Generation of deletion and point mutations with one primer in a single cloning step Biotechniques 29 2000 970 972
29. S. Mayor, and H. Riezman Sorting GPI-anchored proteins Nat Rev Mol Cell Biol 5 2004 110 120
30. M. Noda, J. Oh, R. Takahashi, S. Kondo, H. Kitayama, and C. Takahashi RECK: a novel suppressor of malignancy linking oncogenic signaling to extracellular matrix remodeling Cancer Metastasis Rev 22 2003 167 175
31. T. Mori, R. Moriuchi, E. Okazaki, K. Yamada, and S. Katamine Tgat oncoprotein functions as an inhibitor of RECK by association of the unique C-terminal region Biochem Biophys Res Commun 355 2007 937 943
32. A. Roberti, D. La Sala, and C. Cinti Multiple genetic and epigenetic interacting mechanisms contribute to clonally selection of drug-resistant tumors: current views and new therapeutic prospective J Cell Physiol 207 2006 571 581
33. G. Szakács, J.K. Paterson, J.A. Ludwig, C. Booth-Genthe, and M.M. Gottesman Targeting multidrug resistance in cancer Nat Rev Drug Discov 5 2006 219 234
34. H.K. Lee, C. Xiang, S. Cazacu, S. Finniss, G. Kazimirsky, and N. Lemke GRP78 is overexpressed in glioblastomas and regulates glioma cell growth and apoptosis Neuro Oncol 10 2008 236 243